The Harmans/BWI-1 FDA-licensed facility, at approximately 200,000 sq. ft., will house 10 CGMP manufacturing suites, including fill/finish, and contains central services labs, testing labs, and acts as our central warehouse and supply chain hub for Catalent Gene Therapy.
The Harmans/BWI-2 facility, at approximately 145,000 sq. ft., is under development and will house 5 CGMP manufacturing suites and cold storage warehousing.
Both facilities support Phase 3 through commercial manufacturing of advanced therapeutic products including AAV and other viral vectors, vaccines, and oncolytic immunotherapies.
Size: 345,000+ ft. 2
7555 Harmans Road
Harmans, MD 21077
Harmans, MD Location
|7555 Harmans Rd, Harmans, MD 21077, USA|
Reach out to one of our experts to discuss any of our offerings or a specific solution for your project challenges.